For PatientPoint's patient engagement platform, should we emphasize developing more personalized health content or increasing advertising opportunities for pharmaceutical partners?

Introduction

The trade-off we're examining for PatientPoint's patient engagement platform is whether to prioritize developing more personalized health content or increasing advertising opportunities for pharmaceutical partners. This decision involves balancing user value with revenue generation, potentially impacting patient outcomes and business sustainability. I'll analyze this trade-off through multiple lenses, considering stakeholder impacts, metrics, and experimental approaches to inform a strategic recommendation.

Step 1

Clarifying Questions (3 minutes)

• Based on the platform's current state, I'm thinking we might be facing user engagement challenges. Could you share some insights on our current user retention and engagement metrics?

Why it matters: Helps determine if personalization is needed to improve user experience. Expected answer: Moderate engagement, room for improvement. Impact on approach: High engagement might shift focus towards monetization, while low engagement would prioritize personalization.

• Considering our business model, I assume advertising is a significant revenue stream. What percentage of our revenue currently comes from pharmaceutical partnerships?

Why it matters: Indicates the financial impact of focusing on advertising. Expected answer: 50-70% of revenue from pharma partnerships. Impact on approach: A higher percentage would make increasing ad opportunities more attractive.

• Looking at our user base, I'm curious about the diversity of health conditions represented. Can you provide an overview of the main health segments we serve?

Why it matters: Influences the potential impact and complexity of personalization efforts. Expected answer: Wide range of chronic conditions with some dominant segments. Impact on approach: More diverse conditions increase the value of personalization but also its complexity.

• Regarding our technical capabilities, I'm wondering about our current personalization engine. How sophisticated is our ability to deliver tailored content?

Why it matters: Determines the feasibility and timeline for enhancing personalization. Expected answer: Basic personalization in place, room for improvement. Impact on approach: Advanced capabilities might make personalization a quicker win, while limited capabilities could extend the timeline.

• Considering resource allocation, how is our product team currently split between content development and ad tech?

Why it matters: Indicates current priorities and potential for reallocation. Expected answer: 60% content, 40% ad tech. Impact on approach: Even split might suggest maintaining balance, while a skew could indicate a need to rebalance.